PTGS2 and colonic neoplasm: A study using bioactive compounds of pomegranate, such as ellagitannins and punicalagin, showed that the inflammatory cell signaling in colon cancer cells was suppressed by significantly decreasing the cyclooxygenase-2 (COX-2) expression [75].